LUNDEOS caps moll 20000 UI 4 pce
7680677960017
CH-67796
A11CC05
07.02.3.
Reimbursement limitations:
VIFEROLD3
Traitement d'une carence sévère prouvée en vitamine D (concentration sérique de 25-hydroxycholécalciférol <25 nmol/l ou …
1 / 3
google
Details
- Product number
- 6779602
- CPT
- -
- Packaging group
- 4
- Unit
- Kapsel(n)
- Composition
- cholecalciferolum 20000 U.I. corresp. cholecalciferolum 500 µg, triglycerida media, int-rac-alpha-tocopherylis acetas, gelatina, glycerolum, sorbitolum liquidum partim deshydricum corresp. sorbitolum max. 3.64 mg, aqua purificata, pro capsula.
Articles (1)
Lundeos, capsule molle
capsule molle
4
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
20000.0 UI | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
500.0 UG | Substance | WIIS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 13.90
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/08/2022
Authorization holder
Labatec Pharma SA
1217 Meyrin
Authorization information
- Swissmedic authorization number
- 67796
- Drug name
- Lundeos, capsule molle
- Galenic form
- KAPWE
- ATC Code
- A11CC05
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 17/02/2022
- Authorization expiration date
- 16/02/2027
- IT number
- 07.02.3.
- Domain
- Human medicine
Packaging details
- Description (FR)
- LUNDEOS caps moll 20000 UI 4 pce
- Description (DE)
- LUNDEOS Weichkaps 20000 IE 4 Stk
- Market launch
- 17/02/2022
- Narcotic (BTM)
- No